Key facts
- This page summarizes Peter E. Boyd's Form 4 filing for Aquestive Therapeutics, Inc. (AQST).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Sep 2026, 09:21.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Exercise of in-the-money or at-the-money derivative security
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Exercise of in-the-money or at-the-money derivative security
Additional SEC filing notes
Footnote F1
Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share.